世界の過敏性腸症候群治療市場規模・現状・予測2021-2027

【英語タイトル】Global Irritable Bowel Syndrome Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR3283)・商品コード:QY21APR3283
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、過敏性腸症候群治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(便秘過敏性腸症候群、下痢過敏性腸症候群、便秘・下痢過敏性腸症候群)、用途別市場規模(病院、クリニック、在宅ケア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・過敏性腸症候群治療の市場動向
・企業の競争状況、市場シェア
・過敏性腸症候群治療の種類別市場規模(便秘過敏性腸症候群、下痢過敏性腸症候群、便秘・下痢過敏性腸症候群)
・過敏性腸症候群治療の用途別市場規模(病院、クリニック、在宅ケア)
・過敏性腸症候群治療の北米市場規模2016-2027(アメリカ、カナダ)
・過敏性腸症候群治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・過敏性腸症候群治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・過敏性腸症候群治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・過敏性腸症候群治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bausch Health、Sucampo Pharmaceuticals、Abbott Laboratories、Lexicon Pharmaceuticals、Salix Pharmaceuticals、Ironwood Pharmaceuticals、GlaxoSmithKline、Allergan)
・結論
【レポートの概要】

Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.
Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population, increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the forecast period.

Market Analysis and Insights: Global Irritable Bowel Syndrome Treatment Market
The global Irritable Bowel Syndrome Treatment market size is projected to reach US$ 2511 million by 2026, from US$ 1864.1 million in 2019, at a CAGR of 4.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Irritable Bowel Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Irritable Bowel Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Irritable Bowel Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Irritable Bowel Syndrome Treatment market.

Global Irritable Bowel Syndrome Treatment Scope and Market Size
Irritable Bowel Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with alternating Constipationand Diarrhea

Segment by Application
Hospitals
Clinics
Homecare settings

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch Health
Sucampo Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals
Salix Pharmaceuticals
Ironwood Pharmaceuticals
GlaxoSmithKline
Allergan

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Irritable Bowel Syndrome with Constipation
1.2.3 Irritable Bowel Syndrome with Diarrhea
1.2.4 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare settings
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome Treatment Market Perspective (2016-2027)
2.2 Irritable Bowel Syndrome Treatment Growth Trends by Regions
2.2.1 Irritable Bowel Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Irritable Bowel Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Irritable Bowel Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Irritable Bowel Syndrome Treatment Industry Dynamic
2.3.1 Irritable Bowel Syndrome Treatment Market Trends
2.3.2 Irritable Bowel Syndrome Treatment Market Drivers
2.3.3 Irritable Bowel Syndrome Treatment Market Challenges
2.3.4 Irritable Bowel Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome Treatment Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Irritable Bowel Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Irritable Bowel Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome Treatment Revenue
3.4 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Treatment Revenue in 2020
3.5 Irritable Bowel Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Irritable Bowel Syndrome Treatment Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Type (2022-2027)

5 Irritable Bowel Syndrome Treatment Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Irritable Bowel Syndrome Treatment Market Size (2016-2027)
6.2 North America Irritable Bowel Syndrome Treatment Market Size by Type
6.2.1 North America Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Irritable Bowel Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Irritable Bowel Syndrome Treatment Market Size by Application
6.3.1 North America Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Irritable Bowel Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Irritable Bowel Syndrome Treatment Market Size by Country
6.4.1 North America Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Irritable Bowel Syndrome Treatment Market Size (2016-2027)
7.2 Europe Irritable Bowel Syndrome Treatment Market Size by Type
7.2.1 Europe Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Irritable Bowel Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Irritable Bowel Syndrome Treatment Market Size by Application
7.3.1 Europe Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Irritable Bowel Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Irritable Bowel Syndrome Treatment Market Size by Country
7.4.1 Europe Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Irritable Bowel Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Irritable Bowel Syndrome Treatment Market Size by Type
9.2.1 Latin America Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Irritable Bowel Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Irritable Bowel Syndrome Treatment Market Size by Application
9.3.1 Latin America Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Irritable Bowel Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Irritable Bowel Syndrome Treatment Market Size by Country
9.4.1 Latin America Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome Treatment Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Sucampo Pharmaceuticals
11.2.1 Sucampo Pharmaceuticals Company Details
11.2.2 Sucampo Pharmaceuticals Business Overview
11.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.2.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.2.5 Sucampo Pharmaceuticals Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Introduction
11.3.4 Abbott Laboratories Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Lexicon Pharmaceuticals
11.4.1 Lexicon Pharmaceuticals Company Details
11.4.2 Lexicon Pharmaceuticals Business Overview
11.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.4.4 Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.4.5 Lexicon Pharmaceuticals Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Details
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.5.4 Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Ironwood Pharmaceuticals
11.6.1 Ironwood Pharmaceuticals Company Details
11.6.2 Ironwood Pharmaceuticals Business Overview
11.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.6.4 Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.6.5 Ironwood Pharmaceuticals Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Irritable Bowel Syndrome Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Irritable Bowel Syndrome Treatment Introduction
11.8.4 Allergan Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021)
11.8.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Irritable Bowel Syndrome with Constipation
Table 3. Key Players of Irritable Bowel Syndrome with Diarrhea
Table 4. Key Players of Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Table 5. Global Irritable Bowel Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Irritable Bowel Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Irritable Bowel Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Treatment Market Share by Regions (2016-2021)
Table 9. Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Treatment Market Share by Regions (2022-2027)
Table 11. Irritable Bowel Syndrome Treatment Market Trends
Table 12. Irritable Bowel Syndrome Treatment Market Drivers
Table 13. Irritable Bowel Syndrome Treatment Market Challenges
Table 14. Irritable Bowel Syndrome Treatment Market Restraints
Table 15. Global Irritable Bowel Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome Treatment Market Share by Players (2016-2021)
Table 17. Global Top Irritable Bowel Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome Treatment as of 2020)
Table 18. Ranking of Global Top Irritable Bowel Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Irritable Bowel Syndrome Treatment Product Solution and Service
Table 22. Date of Enter into Irritable Bowel Syndrome Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Irritable Bowel Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bausch Health Company Details
Table 63. Bausch Health Business Overview
Table 64. Bausch Health Irritable Bowel Syndrome Treatment Product
Table 65. Bausch Health Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 66. Bausch Health Recent Development
Table 67. Sucampo Pharmaceuticals Company Details
Table 68. Sucampo Pharmaceuticals Business Overview
Table 69. Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Product
Table 70. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 71. Sucampo Pharmaceuticals Recent Development
Table 72. Abbott Laboratories Company Details
Table 73. Abbott Laboratories Business Overview
Table 74. Abbott Laboratories Irritable Bowel Syndrome Treatment Product
Table 75. Abbott Laboratories Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 76. Abbott Laboratories Recent Development
Table 77. Lexicon Pharmaceuticals Company Details
Table 78. Lexicon Pharmaceuticals Business Overview
Table 79. Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Product
Table 80. Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 81. Lexicon Pharmaceuticals Recent Development
Table 82. Salix Pharmaceuticals Company Details
Table 83. Salix Pharmaceuticals Business Overview
Table 84. Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Product
Table 85. Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 86. Salix Pharmaceuticals Recent Development
Table 87. Ironwood Pharmaceuticals Company Details
Table 88. Ironwood Pharmaceuticals Business Overview
Table 89. Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Product
Table 90. Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 91. Ironwood Pharmaceuticals Recent Development
Table 92. GlaxoSmithKline Company Details
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Irritable Bowel Syndrome Treatment Product
Table 95. GlaxoSmithKline Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 96. GlaxoSmithKline Recent Development
Table 97. Allergan Company Details
Table 98. Allergan Business Overview
Table 99. Allergan Revenue in Irritable Bowel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 100. Allergan Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Irritable Bowel Syndrome with Constipation Features
Figure 3. Irritable Bowel Syndrome with Diarrhea Features
Figure 4. Irritable Bowel Syndrome with alternating Constipationand Diarrhea Features
Figure 5. Global Irritable Bowel Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Homecare settings Case Studies
Figure 9. Irritable Bowel Syndrome Treatment Report Years Considered
Figure 10. Global Irritable Bowel Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Irritable Bowel Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Irritable Bowel Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Irritable Bowel Syndrome Treatment Market Share by Regions (2022-2027)
Figure 14. Global Irritable Bowel Syndrome Treatment Market Share by Players in 2020
Figure 15. Global Top Irritable Bowel Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Treatment Revenue in 2020
Figure 17. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Irritable Bowel Syndrome Treatment Market Share by Type (2016-2027)
Figure 21. North America Irritable Bowel Syndrome Treatment Market Share by Application (2016-2027)
Figure 22. North America Irritable Bowel Syndrome Treatment Market Share by Country (2016-2027)
Figure 23. United States Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Irritable Bowel Syndrome Treatment Market Share by Type (2016-2027)
Figure 27. Europe Irritable Bowel Syndrome Treatment Market Share by Application (2016-2027)
Figure 28. Europe Irritable Bowel Syndrome Treatment Market Share by Country (2016-2027)
Figure 29. Germany Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Irritable Bowel Syndrome Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Irritable Bowel Syndrome Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Irritable Bowel Syndrome Treatment Market Share by Region (2016-2027)
Figure 39. China Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Irritable Bowel Syndrome Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Irritable Bowel Syndrome Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Irritable Bowel Syndrome Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Irritable Bowel Syndrome Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Irritable Bowel Syndrome Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Irritable Bowel Syndrome Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Irritable Bowel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 59. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 60. Abbott Laboratories Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 61. Lexicon Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 62. Salix Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 63. Ironwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 65. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Bausch Health、Sucampo Pharmaceuticals、Abbott Laboratories、Lexicon Pharmaceuticals、Salix Pharmaceuticals、Ironwood Pharmaceuticals、GlaxoSmithKline、Allergan

★調査レポート[世界の過敏性腸症候群治療市場規模・現状・予測2021-2027] (コード:QY21APR3283)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の過敏性腸症候群治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆